If you want whiter teeth, you don't need to shell out huge amounts on professional services. DIY teeth whitening products can get you a brighter smile at home. We've found the best comprehensive ...
In week 4, it was Teeth's turn to reveal herself - and the identity of the celebrity underneath truly shocked the judges, who had previously guessed the likes of Fearne Cotton, Emily Atack ...
Teeth was Mel Giedroyc all along! (Picture: Danny Lawson/PA Archive/PA Images) The panel failed miserably in guessing her identity (Picture: Hoda Davaine/Dave Benett/Getty Images for Women of the ...
What if, instead, they could regrow their pearly whites, perhaps at a fraction of the cost? Approaches that replace — rather than patch up — teeth with crowns or fillings may be closer than you think.
Aardvark Therapeutics filed for an IPO Thursday night, making it the sixth biotech in line this year for a potential listing … ...
AbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to introduce a new class of treatments across oncology and immunology.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see new data on a next-generation obesity candidate from ...
AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and immunology, with the deal worth $1.64bn. The collaboration and ...
Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion in milestone payments. AbbVie and Neomorph have announced a collaboration ...
AbbVie has completed the acquisition of Nimble Therapeutics. Credit: © AbbVie Inc. All rights reserved. AbbVie and Neomorph are forming a partnership and option-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback